Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.GSK and Vir announce EMA review of VIR-7831 for early treatment of Covid-19
GlaxoSmithKline and Vir Biotechnology have announced the European Medicines Agency (EMA) review of VIR-7831 (GSK4182136) for the early treatment of Covid-19.
Disease Specific Immunochemistry
-
16 Apr 2021
-
19 Mar 2021
Boston Pharmaceuticals signs three-year agreement with GSK
The US-based clinical stage biopharmaceutical company Boston Pharmaceuticals has announced the signing of a unique three-year out-license and option agreement with the UK-based GlaxoSmithKline (GSK).
-
26 Feb 2021
Merck signs agreement to purchase Pandion Therapeutics
World’s leading biopharmaceutical firm Merck has announced that it has entered into a definitive agreement to purchase Pandion Therapeutics through a subsidiary, for a total equity value of about $1.85m.